Index Entries

Patrick Chambers
November 3, 2023
Qeios

Dr. Chambers is a pathologist and former Managing Director at the Torrance Memorial Medical Center in California. 

"Introduction

Many oncologists and pathologists are reporting an increase in cancers, especially in those under 40, in the aftermath of COVID-19 and its vaccines. This spike and associated claims of 'turbo cancers' are denied, ascribed to other considerations, or dismissed as secondary to vaccine benefits. DNA plasmid contamination, inflammatory lipid nanoparticles, or other claimed toxic elements in the vaccine are not discussed.

Follow up data to prove or not is time dependent, but a pattern may be emerging. The pandemic and its LC [long Covid] aftermath have driven a tsunami of relevant research. This report will tap the wealth of that research on the spike protein S... Although many claim that the benefit/risk ratio is strongly in favor of COVID-19 vaccination for the elderly and those with comorbidities, the relevant physiology suggests otherwise...

5. The Spike Protein S, Mannose, and Cancer

... Exposure to CD147 on the spike protein S, whether via infection or vaccination, poses significant long term risks. Its overexpression is linked to tumorigenesis, tumor progression, and predicts a poor prognosis.

With respect to vaccination the spike protein S is not limited to the site of injection, but can circulate. According to analysis of a Japanese biodistribution study of the Pfizer mRNA vaccine, the S1 subunit could be found in spleen, bone marrow, liver, lungs, lymph nodes, heart, brain and spinal cord, eyes, kidneys, adipose tissue, adrenal glands, ovaries and uterus, testes, pancreas, prostate, stomach and intestines, thyroid, thymus, muscle, and salivary glands, although S1 reportedly disappeared after 14 days. LC with persistent spike protein S can potentiate EMT/EndMT [epithelial mesenchymal transition] in the TME [tumor microenvironment] with subsequent tumor invasion/metastasis in many organs distant to the injection site, bypassing the blood-gas barrier...

Conclusion

... Elevated TNFα is linked with aggressive TNBC [triple negative breast cancer] and aggressive colon cancers. The former is more commonly encountered in women under 40, African Americans, Hispanics, the obese, the vitamin D deficient, and the magnesium deficient. Both are claimed to be vaccine induced turbo cancers. If the presented scenario based on the most recent physiologic findings is correct, then the repeated doses of the vaccine and the recurrent infections they enable both stoke repeated exposures to elevated TNFα. In those susceptible, as described, these exposures carry great risk."

Pre-print article

document
adverse events,cancer,COVID-19,vaccine dynamics,vaccines